4-苯基丁酸钠

4-苯基丁酸钠（CAS 1716-12-7）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的记载用途

Phenylbutyrate and sodium benzoate are orphan drugs approved for the treatment of hyperammonemia in patients with urea cycle disorders, a series of at least 8 rare genetic enzyme deficiencies. The urea cycle is the major pathway of elimination of excess nitrogen including ammonia, and absence of one of the urea cycle enzymes often causes elevations in serum ammonia which can be severe, life-threatening and result in permanent neurologic damage and cognitive deficiencies. Both phenylbutyrate and sodium benzoate actBreast Feeding; Lactation; Milk, Human; Urea Cycle Disorders

同义词与商品名

Sodium 4-phenylbutyrate; SODIUM PHENYLBUTYRATE; 1716-12-7; Buphenyl; TriButyrate; Benzenebutanoic acid, sodium salt; Ammonaps; Pheburane; 4-phenylbutyric acid, sodium salt; OLPRUVA; DTXSID7040948; NT6K61736T; ACER-001; NSC-657802; DTXCID5020948; CHEBI:75316

已收录的法规名录

GHS notification summary	2.3% (1 / 44)

GHS 危害分类

GHS notification summary	2.3% (1 / 44)
Reported hazard statements	H319 (93.2%)

This chemical does not meet GHS hazard criteria for 2.3% (1 of 44) of reports.

H319 (93.2%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

公开数据库对它的描述

Sodium 4-Phenylbutyrate · CAS 1716-12-7 · C10H11NaO2. UNII NT6K61736T.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。